Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Denium Therapeutics, Inc - Common Shares (NQ:MNMD)

14.87 +0.99 (+7.13%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 13, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Denium Therapeutics, Inc - Common Shares

< Previous 1 2
...
28 29 30 31 32 33 34 35 Next >
News headline image
Mind Medicine, Allied Among Top Psychedelic Movers Of Today ↗
GAINERS: Small Pharma (OTC:DMTTF) shares closed up 5.04% at $0.17 
Via Benzinga
News headline image
New Psychedelics ETF Launches On NYSE Arca ↗
Elemental Advisors Inc. has launched its first ETF, composed of companies involved in research, development, production or use of psychedelics to address medical conditions. The PSYK ETF (NYSE: PSYK)... 
Via Benzinga
News headline image
Mindset Pharma, Allied Among Top Psychedelic Movers Of Today ↗
GAINERS: Mindset Pharma (OTC:MSSTF) shares closed up 15.70% at $0.69 
Via Benzinga
News headline image
ATAI Life Sciences, Mind Medicine Among Top Psychedelic Movers Of Today ↗
GAINERS: ATAI Life Sciences (NASDAQ:ATAI) shares closed up 7.89% at $5.33 
Via Benzinga
News headline image
MindMed Successfully Completes Phase 1 Trial Of 18-MC ↗
This article was originally published on Microdose... 
Via Benzinga
News headline image
The Psychedelic & Marijuana Drug Stocks Index Dropped -30% In January ↗
This article updates the performances of 16 clinical-stage psychedelic and marijuana drug companies researching the treatment of a wide variety of mental illnesses. 
Via Talk Markets
News headline image
Psychedelic Stock Gainers And Losers From January 28, 2022 ↗
GAINERS: Mindset Pharma (OTC:MSSTF) shares closed up 17.86% at $0.57 
Via Benzinga
News headline image
Bruce Linton's Óskare Capital Announces Strategic Cannabis Investment Partnership ↗
Óskare Capital, the life science and deep tech fund owned by renown investor Bruce Linton and Alpha Blue Ocean, a global investment firm, announced on Thursday the formation of a strategic partnership... 
Via Benzinga
News headline image
Mind Medicine, Small Pharma Among Top Psychedelic Movers Of Today ↗
GAINERS: Mindset Pharma (OTC:MSSTF) shares closed up 6.29% at $0.49 
Via Benzinga
News headline image
Mind Medicine, Small Pharma Among Top Psychedelic Movers Of Today ↗
GAINERS: Small Pharma (OTC: 
Via Benzinga
News headline image
MindMed Shares Soar After FDA Approves First Commercial Clinical Trial On LSD In 40 Years ↗
MindMed (NASDAQ:MNMD), a drug development company in the p... 
Via Benzinga
News headline image
51 Biggest Movers From Yesterday ↗
Gainers Sierra Oncology, Inc. (NASDAQ: SRRA) shares climbed 46.2% to close at $22.68 on Tuesday after the company unveiled topline data for momelotinib in myelofibrosis patients... 
Via Benzinga
News headline image
Mind Medicine, Mindset Pharma Among Top Psychedelic Movers Of Today ↗
GAINERS: Mind Medicine (NASDAQ: 
Via Benzinga
News headline image
BNTX Stock Alert: The Omicron Vaccine News That Has BioNTech Shooting Higher Today ↗
BioNTech (BNTX) stock is rising higher on news it and Pfizer (PFE) can test a new Covid-19 vaccine for Omicron in adults. 
Via InvestorPlace
News headline image
MNMD Stock: The FDA Go-Ahead That Has MindMed Investors Feeling Euphoric Today ↗
MindMed (MNMD) stock is getting a buzz today thanks to approval from the FDA to move forward with a clinical trial of MM-120. 
Via InvestorPlace
News headline image
Benzinga Pro's Top 5 Stocks To Watch For Tuesday, Jan. 25, 2022: MSFT, SHOP, ERIC, MNMD, TSLA ↗
Today's 5 Stock Ideas: Microsoft (MSFT) - The company reports Q2 earnings today after the close. Shopify (SHOP) - Shares down premarket. Keybanc lowered its price target... 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From January 24, 2022 ↗
GAINERS: Field Trip Health (NASDAQ: 
Via Benzinga
News headline image
Psyched: Eleusis To Go Public Via Merger, New Psychedelics Bills In Utah, Virginia, Kansas And Missouri ↗
Psychedelics Legalization Gains Momentum Around The Country: Bills Introduced In Utah, Virginia, Kansas And Missouri A wave of psychede... 
Via Benzinga
News headline image
Weekend Update: Only 2 Psychedelic Drug Stocks Are Up YTD ↗
This article updates the performances of the 16 largest capitalized clinical-stage psychedelic and marijuana drug companies researching the treatment of a wide variety of mental illnesses out of a... 
Via Talk Markets
News headline image
Psychedelic Stock Gainers And Losers From January 21, 2022 ↗
GAINERS: GH Research (NASDAQ: 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From January 20, 2022 ↗
GAINERS: Small Pharma (OTC: 
Via Benzinga
News headline image
Revive Therapeutics, GH Research Among Top Psychedelic Movers Of Today ↗
GAINERS: Revive Therapeutics (OTC: 
Via Benzinga
Psilocybin and MDMA Get the Green Light for Medical Use in Canada
FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – January 19, 2022 – After facing legal scrutiny for decades, psychedelics including MDMA and psilocybin received a stamp of... 
Via FinancialNewsMedia
News headline image
Psychedelic Stock Gainers And Losers From January 18, 2022 ↗
GAINERS: Cybin (AMEX: 
Via Benzinga
News headline image
MindMed Launches Study Using Monitoring System For Psychedelic Experiences ↗
Psychedelics biotech company MindMed (NASDAQ:MNMD) has enr... 
Via Benzinga
News headline image
Cannabis Movers & Shakers: MindMed, Halo Collective, Item 9, PSYC, Flora Growth ↗
Stephen Hurst Steps Down From MindMed's Board Of Directors Psychedelic-focused biotech company Mind Medicine Inc 
Via Benzinga
News headline image
Psyched: Canada's Access To Psychedelic Medicines, Psilocybin No Cognitive Side Effects, Psilocybin Bill Washington ↗
Canada Opens New Legal Pathways For Access To Treatment With Psilocybin And MDMA In a groundbreaking decision, the Canadian gov... 
Via Benzinga
News headline image
Pure-Play Marijuana- & Psychedelic Compounds-Based Drug Stocks Index Is Down By 66% From 2021 High ↗
There are 16 remaining constituents of our Marijuana & Psychedelic Compounds-Based Drug Stocks Index is now DOWN -65.9% from its highs in 2021. Here are the details for each of its constituents. 
Via Talk Markets
A Recap of How Psychedelics Fared in 2021
Via Investor Brand Network
News headline image
MindMed Completes Phase 1 Clinical Trial Of Non-Hallucinogenic Proprietary Derivative Of Ibogaine ↗
On Tuesday, Mind Medicine Inc. (NASDAQ:MNMD) (NEO: MM... 
Via Benzinga
< Previous 1 2
...
28 29 30 31 32 33 34 35 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.